{
    "attributes": {
        "action": "Make Erenumab available to Migraine sufferers on the NHS",
        "additional_details": "Please visit The Migraine Trust website.",
        "background": "Migraine causes loss of vision, speech, numbness, confusion, sickness, fatigue and pain for up to 72 hrs, its more common than diabetes, epilepsy and asthma. 190,000 attacks daily cause 25 million sick days a year.  Aimovig halves attacks, NICE rejected it for NHS use.  Private cost \u00a3480 a month.",
        "closed_at": null,
        "created_at": "2019-01-14T21:26:15.157Z",
        "creator_name": null,
        "debate": null,
        "debate_outcome_at": null,
        "debate_threshold_reached_at": null,
        "government_response": null,
        "government_response_at": null,
        "moderation_threshold_reached_at": "2019-01-14T22:47:21.780Z",
        "opened_at": null,
        "rejected_at": "2019-01-24T14:54:49.137Z",
        "rejection": {
            "code": "irrelevant",
            "details": "We can't accept your petition because this is the responsibility of the National Institute for Health and Care Excellence (NICE), not the UK Government or Parliament. "
        },
        "response_threshold_reached_at": null,
        "scheduled_debate_date": null,
        "signature_count": 13,
        "state": "rejected",
        "updated_at": "2019-01-24T14:54:49.143Z"
    },
    "id": 237270,
    "links": {
        "self": "https://petition.parliament.uk/petitions/237270.json"
    },
    "type": "petition"
}